CD274 and ductal breast carcinoma in situ: Staining for PD-L1 demonstrated low levels of PD-L1 positive tumor cells (CK+PD-L1+) or immune cells (PD-L1+ T cells and macrophages) in pre-treatment biopsies of DCIS.